UCB wins “Company Of the Year” at the European Mediscience Awards

Brussels, Belgium, 25 June 2012 – UCB was presented with the European Mediscience Award for 'Company of the Year' at the eleventh annual award ceremony in London. The winner of the ‘Company of the Year’ is recognised as being a well-managed, soundly financed growth business with a well-defined strategy to deliver its key financial, ethical and social ambitions.

“We are delighted that the entire company has been recognised with this award. UCB has transformed itself into a focused biopharma company. Our activities are dedicated to improving the lives of people living with severe diseases of the central nervous system and immune system,” said Roch Doliveux, Chief Executive Officer of UCB. He added, “This award is recognition of the efforts and work of all UCB colleagues and we are very thankful for this.”

On announcing the award the judging panel described UCB as a ‘company that has transformed itself over the past eight years into a global biopharma leader. It has made acquisitions and divestments, expertly handled patent expiries, and built leading research and development capabilities.’

For further information

France Nivelle, Global Communications, UCB
T +32 2 559 9178, france.nivelle@ucb.com

Antje Witte, Investor Relations, UCB
T +32.2.559.9414, antje.witte@ucb.com

Laurent Schots, Media Relations, UCB
T +32.2.559.9264, laurent.schots@ucb.com

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,000 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2011. UCB is listed on Euronext Brussels (symbol: UCB).

About the European Mediscience Awards
The European Mediscience Awards celebrates the best in private and quoted life science, healthcare and biotech industries. It is the premier event for all stakeholders working in or with private and quoted mediscience companies in Europe and attracts over 500 attendees. More info at: www.mediscience-event.co.uk